AI-powered allergy diagnostics
Milton Essex develops automation systems for allergy diagnosis. SkinSense™ uses AI to streamline patient data collection and deliver fast, objective PRICK skin test analysis—saving time for clinicians and improving consistency.
What SkinSense™ Does
-
Automates the allergy interview to speed up proces and help select the most relevant allergens for testing.
-
Reads PRICK skin test results automatically for consistent, objective outcomes.
How It Works
SkinSense™ observes allergic reactions in two spectra—visible and infrared. This dual-spectrum imaging enables more precise measurement than the human eye alone. Results are processed by AI and exported directly to your EHR/EMR.
Proven in Clinical Use
The system has been clinically tested on ~1,000 patients. Our AI-powered allergy diagnostics platform is currently being prepared for market launch.
Key Benefits
-
-
Higher patient throughput — shorter visits via automated interview and auto-read PRICK analysis; see more patients per day without adding staff.
-
Better use of physician time — fewer manual tasks, more clinical decision-making; delegate routine steps to mid-level staff.
-
Lower operating costs — fewer errors and retests reduce material waste and labor time.
-
Consistent, defensible results — reduced inter-operator variability helps lower medico-legal and insurance risk.
-
Faster time to diagnosis — fewer follow-ups “just for results,” shorter queues, stronger revenue per clinician.
-
Smoother billing and reimbursement — complete digital records and EHR/EMR integration improve data quality and audit trails.
-
Premium service positioning — offer AI-powered allergy diagnostics as a quality differentiator to attract and retain patients.
-
Scalable without new hires — increase test volume without proportional headcount; easier scheduling.
-
Quick onboarding — intuitive workflow shortens ramp-up and training costs.
-
Data for business decisions — trends by allergen/season and team productivity inform purchasing and staffing.
-
Compliance and security — standardized processes, full logs, and exportable data help during audits.
-
Higher patient satisfaction — shorter visits and clear, objective results drive referrals and reviews.
-
Get a demo
Ready to bring AI-powered allergy diagnostics to your clinic? Contact us to schedule a SkinSense™ demo.
Milton Essex S.A. shares have been traded on NewConnect (Warsaw Stock Exchange) since 2020; the Company adheres to the “Good Practices of NC-Listed Firms” policy.
ISIN: PLMLTNS00018 | Ticker: XNCO:MTN
Upcoming reporting dates and ESPI disclosures are published in the IR Calendar.
Investor Relations: ir@miltonessex.eu | +48 510 738 710
Media: press@miltonessex.eu
Follow our progress on LinkedIn and in the ESPI current-report stream.
Human-health portfolio – AI-powered medicine
| Product | What it does | Stage / next milestone |
|---|---|---|
| SkinSense™ | Medical system for AI-powered allergy diagnostics. Delivers an objective score for Prick & Patch skin-allergy tests | Medical-device registration – pilot roll-out in allergy clinics |
| Activescan™ | access system with biometrics and document analysis (authenticity verification) with temperature measurement option. | Pilot project implemented in a large industrial group |
FAQ
What is AI-powered allergy diagnostics?
It uses machine learning and imaging to automate the allergy interview and objectively analyze PRICK test reactions, improving speed, accuracy, and consistency.
How are PRICK test results analyzed?
SkinSense™ applies dual-spectrum (visible + infrared) imaging and AI processing to measure reactions precisely and deliver objective readouts.
Does SkinSense™ integrate with our EHR/EMR?
Yes. Results are exported directly to your EHR/EMR for seamless documentation and billing.
